WXIBF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - WuXi Biologics (Cayman) Inc

Watchlist Manager

Watchlist

Price: 4.6 USD

Market Cap: $20B

	WuXi Biologics (Cayman) Inc OTC:WXIBF	CN
V	Vesuvius PLC F:V4S	UK
	United Spirits Ltd BSE:532432	IN
	Brightstar Resources Ltd ASX:BTR	AU
D	Deutsche Post AG XMUN:DHL	DE
A	AZZ Inc F:AI7	US
C	Condor Resources Inc OTC:CNRIF	CA
A	Aurinia Pharmaceuticals Inc F:IKAP	CA
F	Franchetti SpA MIL:FCH	IT
C	Champion Pacific Indonesia Tbk PT XMUN:IUD	ID
	ams OSRAM AG OTC:AUKUF	AT
	Kingsoft Cloud Holdings Ltd NASDAQ:KC	CN

Profitability Summary

WuXi Biologics (Cayman) Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

46%

Sustainable 3Y Average Gross Margin

42%

Gross Margin is Increasing

42% > 46%

Exceptional Operating Margin

31%

Sustainable 3Y Average Operating Margin

26%

Operating Margin is Increasing

26% > 31%

Healthy Net Margin

23%

Sustainable 3Y Average Net Margin

20%

Declining Net Margin

25% > 23%

Exceptional Free Cash Flow Margin

12%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.